NM_005529.7:c.*825G>C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_005529.7(HSPG2):​c.*825G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00172 in 372,006 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0034 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00055 ( 0 hom. )

Consequence

HSPG2
NM_005529.7 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.124

Publications

0 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
LDLRAD2 (HGNC:32071): (low density lipoprotein receptor class A domain containing 2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-21822491-C-G is Benign according to our data. Variant chr1-21822491-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 295682.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00344 (516/149798) while in subpopulation AFR AF = 0.0116 (475/41090). AF 95% confidence interval is 0.0107. There are 2 homozygotes in GnomAd4. There are 225 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005529.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
NM_005529.7
MANE Select
c.*825G>C
3_prime_UTR
Exon 97 of 97NP_005520.4
LDLRAD2
NM_001013693.3
MANE Select
c.*276C>G
3_prime_UTR
Exon 5 of 5NP_001013715.2Q5SZI1
HSPG2
NM_001291860.2
c.*825G>C
3_prime_UTR
Exon 97 of 97NP_001278789.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
ENST00000374695.8
TSL:1 MANE Select
c.*825G>C
3_prime_UTR
Exon 97 of 97ENSP00000363827.3P98160
LDLRAD2
ENST00000344642.7
TSL:2 MANE Select
c.*276C>G
3_prime_UTR
Exon 5 of 5ENSP00000340988.2Q5SZI1
LDLRAD2
ENST00000543870.1
TSL:1
c.*218+58C>G
intron
N/AENSP00000444097.1Q5SZI1

Frequencies

GnomAD3 genomes
AF:
0.00344
AC:
515
AN:
149662
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00213
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00386
GnomAD4 exome
AF:
0.000549
AC:
122
AN:
222208
Hom.:
0
Cov.:
0
AF XY:
0.000486
AC XY:
58
AN XY:
119396
show subpopulations
African (AFR)
AF:
0.0134
AC:
87
AN:
6514
American (AMR)
AF:
0.00132
AC:
16
AN:
12158
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
5632
East Asian (EAS)
AF:
0.00
AC:
0
AN:
12530
South Asian (SAS)
AF:
0.0000287
AC:
1
AN:
34882
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
11154
Middle Eastern (MID)
AF:
0.00105
AC:
1
AN:
954
European-Non Finnish (NFE)
AF:
0.00000790
AC:
1
AN:
126574
Other (OTH)
AF:
0.00135
AC:
16
AN:
11810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00344
AC:
516
AN:
149798
Hom.:
2
Cov.:
33
AF XY:
0.00308
AC XY:
225
AN XY:
73170
show subpopulations
African (AFR)
AF:
0.0116
AC:
475
AN:
41090
American (AMR)
AF:
0.00213
AC:
32
AN:
15050
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3448
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4864
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4518
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10124
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67426
Other (OTH)
AF:
0.00382
AC:
8
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00397
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Lethal Kniest-like syndrome (1)
-
-
1
Schwartz-Jampel syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.0
DANN
Benign
0.44
PhyloP100
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151090850; hg19: chr1-22148984; API